Non-viable eschar proteins

Non-viable eschar proteins in wound tissue constitute the necrotic debris and denatured extracellular matrix (ECM) that accumulate following severe tissue injury, such as deep burns or chronic pressure ulcers (StatPearls, 2023). This proteinaceous mass is primarily composed of cross-linked collagen, fibrin, and elastin that have undergone structural degradation due to ischemia or thermal damage (Journal of Wound Care, 2019). In clinical practice, the presence of eschar is a significant impediment to healing, as it physically obstructs the migration of keratinocytes and the formation of healthy granulation tissue (NIH, 2021). Furthermore, eschar serves as a fertile substrate for bacterial proliferation and the development of biofilms, increasing the risk of localized infection and systemic sepsis (PubMed, 2020). Pharmacological intervention focuses on enzymatic debridement, utilizing exogenous proteases like collagenase or bromelain-derived enzymes to selectively hydrolyze these non-viable proteins (FDA, 2022). By liquefying the eschar, these agents facilitate its removal, thereby reducing the inflammatory load and preparing the wound bed for surgical closure or spontaneous healing. This targeted proteolysis is essential for managing complex wounds where surgical debridement may be too invasive or impractical.

Other names

Necrotic tissueWound escharDevitalized tissueSloughBurn escharNecrotic debris

Enzymatic hydrolysis of peptide bonds in denatured proteins, leading to the liquefaction and detachment of necrotic tissue from the wound bed.